Page 11 - Issue 13
P. 11

COVID-19 ACTION
   Medical device photos from the UCL which GTMA is working with on producing ventilators. All photos reproduced with permission ©James Tye/UCL.
In addition, and in parallel to the UCL/F1 ini- tiative, an aerospace consortium led by Smiths and including GTMA supplier Renishaw and other GTMA members has developed a ventilator device ready to go into production at the time of writing this.
“We have engaged with this consortium also to offer the Medical Cluster supply chain resource,” said Julia.
The VentilatorChallengeUK Consortium is a significant UK industrial, technology and engineering resource led by Dick Elsy, CEO of the High Value Manufacturing Catapult.
In late March it was “working hard to investi- gate production of a range of ventilator design options” to meet a high-level specifi- cation for a Rapidly Manufactured Ventilator System (RMVS) developed by clinicians and the Medicines and Healthcare products Regulatory Agency (MHRA).
As well as Renishaw other companies involved include Airbus, BAE Systems, Ford,
Rolls-Royce, Siemens, Smiths Group, Thales and Unilever. Several UK-based F1 teams are also involved.
REGISTER NOW
Julia said: “Alongside specific initiatives I would encourage GTMA members to register with Alan (alan@gtma.co.uk) to join the GTMA Medical Cluster and then also self-register on the government portal (weblink below).
“Moving forward we recognise that this
need to embed manufacturing of key equip- ment in the UK is a key driver and we will make every effort through the Medical Cluster and through our Reshoring network to sup- port manufacturers, promoting the benefits of reshoring.”
www.gtma.co.uk alan@gtma.co.uk www.gov.uk/coronavirus-support-from- business www.ventilatorchallengeuk.com
GTMA
contribution is
'invaluable'
The following message of thanks has been received from UCL, UCLH and Mercedes-AMG HPP team to the GTMA:
‘A breathing aid that can help keep Covid-19 patients out of intensive care has been adapted by our
team of mechanical engineers at UCL and clinicians at UCLH working with Mercedes-AMG HPP and Oxford Optronix.
The breathing aid, known as Continuous Positive Airway Pressure (CPAP), has been used extensively in hospitals in Italy and China to help Covid-19 patients with serious lung infections to breathe more easily, when oxygen alone is insufficient. You can find out more about our work online here: bit.ly/uclmercedescovid19.
DEEP APPRECIATION
Our device has been approved for use in the NHS and we are pleased to tell you that the government has ordered up to 10,000 to be supplied to hospitals around the country ahead of the predict- ed surge in Covid-19 hospital admis- sions.
We want to extend our deepest appreci- ation to the members of the GTMA that have responded to our call for support in this.
Over 60 of you have submitted named contact details for this initiative and many of these have been actively engaged in our supply chains.
This contribution has been invaluable and played a critical role in allowing us to develop the CPAP device so rapidly to support our NHS colleagues during this time. Thank you.
We will continue to push forward over the upcoming weeks to meet this need and welcome the continued support from GTMA members.
From Professor Tim Baker
of the University College, London (UCL)
  The letter that began it all...
This is the letter received by GTMA from Professor Tim Baker of UCL Mechanical Engineering at the University College, London:
“In response to the COVID-19 pandemic, a working group has been formed around the Intensive Care Unit at University College London Hospital. The purpose is to provide ventilators for the growing demand in London and nationally.
The team comprises core members of the front line medical team, as well as members of the Mechanical Engineering department at UCL specialising in medical research and manufacturing. The group is linked to the government through the Department of Health and the Department for International Development.
Manufacturers and suppliers with experience in precision manufacturing are being sought – including companies involved in producing components for hi-tech industries not usually associated with medical equipment, such as aerospace and automotive.
Those with motorsport experience have been identified as being of particular interest owing to the timescales involved.
At this early stage (March 17), trade organi- sations are being asked to put out a call to their members for expressions of interest.
Whilst technical details are being finalised, the team will be putting in place a supply chain that is ready to respond as soon as designs are released. Further details will become available as the week progresses.”
 11
  ‘





























































   9   10   11   12   13